Webinar Date/Time: Thu, May 18, 2023 11:00 AM EDT
Learn about the different types of uncertainty sources and analysis, and how to apply it to take your forecast to the next level.
Register Free: https://www.pharmexec.com/pe_w/unknown-forecasting
Event Overview:
Commercial forecasting in the biopharmaceutical industry always comes with some uncertainty, especially given the ever-evolving life sciences marketplace. Uncertainty arises from multiple sources including innovation across therapy areas such as oncology, immunology and neurology as well as patient population dynamics, access and price. Thus, having the ability to effectively capture, analyze, and develop insights on uncertainty is a key aspect of life sciences forecasting and decision-making.
In this webinar, we’ll learn the tradeoffs between different types of uncertainty analysis - from traditional scenario-based planning to more sophisticated Monte Carlo analysis - and discuss how to effectively present and improve their integration in your organization, using cutting-edge forecasting tools for both singular assets and whole portfolios.
Three Key Take-Aways:
Speakers:
David Wolter, MBA
VP Consulting Services
IQVIA
David Wolter is a Vice President of IQVIA’s Consulting Services group. He has more than 15 years of experience in management consulting and modeling system development and is the lead of the US Strategy & Portfolio Analysis Solution Team. His past work has included product valuations, detailed forecasting exercises, analogue analyses, and decision-analysis/strategy projects – both with and without the support of software tools. David has an MBA from Stanford GSB, an MS in Accounting from DePaul University and a BA in Economics from Amherst College.
Jim Burke, PhD
Associate Principal, Software Solutions, Consulting Services
IQVIA
Jim Burke is an Associate Principal of IQVIA’s Software Solutions Consulting Services group. He has more than 10 years of experience in management consulting and modeling system development. His past work has included applied programming and math skills to experimental particle physics and financial markets. Jim has an PhD from University of Bristol/SLAC, an MPhys from Lancaster University and an MFE from University of Hawaiʻi at Mānoa.
Register Free: https://www.pharmexec.com/pe_w/unknown-forecasting
Cell and Gene Therapy Check-in 2024
January 18th 2024Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.